HORIBA India Private Limited (HIN) organized its annual export conclave - Blossoms 2025 at HIN Nagpur Facility from March 17-19, 2025 which brought together its business partners from Nepal, Bhutan, Bangladesh, Maldives and Sri Lanka on a single platform in a hybrid mode to discuss about the current business scenario at each neighboring country of HORIBA's operation and prospects of growth and development.

The export conclave took a kickstart with introduction to HORIBA and its operations in India and South Asian Association for Regional Cooperation (SAARC) and an overview about its business expansion over the years. Dr. Rajeev Gautam – Senior Corporate Officer of HORIBA Ltd., Japan (HOR, Japan) and President, HIN delivered a motivating presidential address which highlighted the key areas of business expansion in SAARC, its strategy and way forward. 

This prestigious event was graced by virtual keynote address by Arnaud Pradel – President and Chairman of HORIBA ABX SAS (HMFR, France) and Tatsuo Komatsu – General Manager of Distribution and Dx Division of HOR which motivated the business partners toward further succession possibilities.

The event was further followed with an insightful presentation on “HORIBA Overview & Export Vision 2028” by Varun Bhardwaj – Head Export Business (All Group fields) of HIN. Since, HIN’s Bio and Healthcare business has gained significant milestones amongst SAARC, a potential of HORIBA Bio and Healthcare Business and product portfolio was presented to the business partners by Dr. PK Soju – Group Field Officer for Bio and Healthcare group field of HIN.

The program also included a Nagpur Facility walk-around for our business partners to envision the making and import of products happening in this facility followed by the launch of Make-in-India products including Yumizen D20 Digital Morphology Analyzer, Yumizen H500E/H550 Hematology Analyzer, Microsemi CRP, Yumizen C600 Automated Clinical Chemistry Analyzer, RAL Stainer and RAL Stainbox followed by its demonstrations by the product managers.

Day 2 of this export conclave began with overview, product portfolio and potential business expansion in the group fields of Energy and Environment and Materials and Semiconductor which was driven by Mani Iyer – Field Officer of Water Business of HIN; Kunal Soni – Head of Environment Business of HIN and Mani Rajesh – National Sales Manager for Semiconductor Solutions and Materials Industry of HIN respectively.

It was imperative for the HIN team to hear from the Country Managers and Business Partners from each country, therefore a team presentation from each business partner including Techno Biomed Pvt. Ltd., Axis Medibiz Pvt. Ltd., Maxim Incorporation, Japlan Holdings (Pvt) Ltd., Healthcare Diagnostic Solutions Ltd., Joy and 3 Stars Pvt. Ltd. and AllyTech Corporation Ltd. including the country managers from Nepal, Bhutan and Bangladesh was done containing the prospects of growth, current challenges and areas of improvement in the way forward.

The discussion concluded with a Seal the Deal program which fetched business for the Make-in-India products of HIN through business partners across SAARC which was driven by Dr. PK Soju.

The event came to an end with an Award Distribution Ceremony for exemplary business performance of each business partner in the previous year, felicitation, gratitude and Joy and Fun moments with the Business Partners of HIN SAARC business who help us elevate the business in the neighboring countries.

These two days of engagement were filled with immense enthusiasm, Joy and Fun !
 

HORIBA India Private Limited (HIN) under its Corporate Social Responsibility engagement for Fiscal Year 2024-25 in collaboration with Voice of Healthcare (VOH) organized an insightful Roundtable discussion on the topic “The Role of Diagnostics in Curbing the Irrational Use of Antibiotics at the Point of Care” at Hotel Shangri-La, Eros on April 11, 2025.

Under the CSR motto of Together We Grow, HIN supported health and society through this roundtable conference amongst the renowned speakers in the healthcare industry.

Since Antimicrobial Resistance (AMR) is rapidly emerging as one of the world’s most urgent public health crises — followed by climate change — the roundtable provided an essential platform to spotlight the role of diagnostic stewardship in combating this growing challenge.

Despite considerable advances in medical technology, timely, reliable and affordable diagnostic interventions remain inconsistent, often leading to unnecessary use of antibiotics. This roundtable united India’s leading clinicians, policymakers, microbiologists, diagnostic experts and public health specialists to collaboratively explore solutions that can strengthen diagnostic pathways and improve antibiotic stewardship across healthcare settings.

The panel was addressed by Dr. Ravi Gaur (Chairman, Medical Advisory Committee, Oncquest Laboratories and Founder, DRG Path Labs) who moderated the session; Dr. Naveen Nishchal (Founder Chairman, Voice of Healthcare); Dr. Lata Kapoor (Additional Director & Head, Centre for Bacterial Disease and Drug Resistance and AMR Containment, NCDC, Ministry of Health and Family Welfare); Dr. Arjun Dang (CEO, Dr Dangs Lab); Dr. Ankur Mutreja (Director – Strategy, Communications & Partnerships, PATH); Dr. Vikas Manchanda (Professor, Microbiology, Maulana Azad Medical College); Dr. Aakashneel Bhattacharya (Head, Infectious Disease, Paras Hospitals); Dr. Shweta Sharma (Senior Consultant, Microbiology, Yashoda Super Speciality Hospital); Dr. Pooja Wadwa (Clinical Director, Critical Care Medicine, Marengo Asia Hospitals); Dr. Ichha Kaur (Senior Consultant, Anaesthesia, Paras Hospitals); Dr. Simant Jha (Director, Critical Care, PSRI Hospital); Dr. Tariq Ali (Director, Critical Care, Medanta - The Medicity); Dr. Ashish Bajaj(Consultant Microbiologist & Infection Control Officer, CK Birla Hospital); Dr. Prashant Nag (Chief Operating & Medical Officer, Redcliffe Labs) and Dr. Rajeev Gautam (Senior Corporate Officer of HORIBA, Ltd., (HOR, Japan)  and President of HIN) to collaboratively explore solutions that can strengthen diagnostic pathways and address points like how irrational use of antibiotics is a threat for the present generation and is giving rapid emergence to Anti-Microbial Resistance (AMR).

This roundtable conference was conducted in two rounds, discussion in Round One centered around identifying the persistent gaps in India’s AMR response — from diagnostic turnaround delays and limited lab infrastructure to an over-reliance on empirical treatments in ICUs, OPDs, and emergency settings, where decisions are often made without timely, evidence-based diagnostic confirmation. Experts collectively agreed on the urgent need to empower clinicians with faster, reliable point-of-care diagnostic solutions, improve real-time lab-clinician communication, and implement stewardship protocols.

Further on, as we moved to Round Two, the conversation shifted toward scalable solutions — with proposals including hospital antibiogram integration, AMR surveillance networks, syndromic PoC testing programs, public-private diagnostic partnerships and large-scale clinician stewardship training initiatives. The experts emphasized the importance of bridging diagnostic gaps beyond metro cities — into tier-2, tier-3 cities, and rural setups — and called for collaborative national awareness campaigns, policy support and standardized diagnostic-led antimicrobial stewardship frameworks.

This meaningful roundtable session under the CSR initiative of HIN marks a progressive step towards uniting India’s clinical, diagnostic and policy voices under a common mission of placing diagnostics at the center of antimicrobial resistance containment, promoting responsible, evidence-based healthcare and advancing India’s global leadership in combating antimicrobial resistance.

HORIBA is strengthening its contribution towards society and youth of India by embracing its CSR motto of “Together We Grow” and to embrace this across the nation, HIN has strengthened its CSR activity at Indian Institute of Technology, Delhi for the second consecutive year now.

In Fiscal Year 2024-25, HIN has granted CSR funding to support three technical research and development projects which will benefit the society and India’s growing economy in the near future. 

The three projects which HIN has partnered to support at Indian Institute of Technology (IIT), Delhi are as below:

1. Development of low-cost high-torque density reduced rare-earth magnet-based EV Motor for which Prof. Saptarshi Basak, Centre for Automotive Research and Tribology (CART), IIT Delhi is going to be the lead for execution and knowledge sharing with students to get the expected outcomes.

1. 3D printing of smart fabrics and innovative design prototypes is the second research and development project which HIN will be supporting, this falls under the mentorship of Mr. Sagar Sarkar; Assistant Professor; Department of Mechanical Engineering; IIT Delhi.

1. Development of intermediate temperature proton conducting solid oxide electrolysis cell (H-SOEC) for green hydrogen generation which will be supported by the guidance and knowledge sharing of Prof. Suddhasatwa Basu, Department of Chemical Engineering, IIT Delhi.

On April 11, 2025, a Memorandum of Understanding (MOU)signing ceremony to extend this CSR partnership between HIN and IIT Delhi was conducted at the premises of the institute. The MOUs were exchanged between Professor Preeti Ranjan Panda – Dean, Corporate Relations. Professor, CSE&SIT, IIT Delhi and Dr. Rajeev Gautam – Senior Corporate Officer of HORIBA Ltd., (HOR, Japan) and President of HIN in kind presence of Mr. Sagar Sarkar, Assistant Professor, Department of Mechanical Engineering, IIT Delhi and Prof. Saptarshi Basak, Centre for Automotive Research and Tribology (CART), IIT Delhi; Staff of Corporate Relations Office, IIT Delhi and delegates from HIN.

HIN India has been supporting with CSR funding for technical equipment which have played a vital role in supporting the education and skill development of youth with disabilities, making significant impact on their learning journey.

We have further strengthened this collaboration by supporting three key technical research projects in major areas of innovation and progress, which is expected to lead to better outcomes and pave the way for an even stronger partnership focused on empowering the next generation of India.

This CSR initiative aims at making India a stronger country in scientific developments, research and development. It also addresses the focus on strengthening collaboration with more technical advanced research institute of India to support the nation’s youth on the academic front.

We are proud to share that HORIBA India has been recognized as the Best Healthcare Brand 2025 by The Economic Times Group. The award was presented at the 8th edition of the Economic Times Now Best Healthcare Brands held on 25 June 2025 at Hotel Sahara Star, Mumbai.

Dr. Rajeev Gautam (Senior Corporate Officer – HORIBA Ltd., Japan and President – HORIBA India) received the accolade from the Chief Guest, Dr. Ajeet Madhavrao Gopchade (Member of Parliament, Rajya Sabha), in recognition of our sustained excellence and leadership in healthcare.

This marks the second consecutive year that HORIBA India has earned this prestigious honour.

Prior to the awards ceremony, Dr. Gautam joined an expert panel discussion on “The Business of Healing: Trends, Turbulence and Transformation,” alongside distinguished leaders from across the healthcare sector:

• Dr. Santosh Shetty, CEO & Executive Director, Kokilaben Dhirubhai Ambani Hospital
• Gautam Khanna, CEO, PD Hinduja Hospital
• Anurag Yadav, CEO, Gleneagles Healthcare India
• Anil Kumar, Managing Director, Air Liquide Medical Systems
• Harsh Parekh, Co-Founder, PharmEasy

The event built around the theme “Built to Heal. Born to Lead” drew over 40 leading healthcare brands and promises to be a turning point for networking and industry collaboration. Following the panel, the Best Healthcare Brands of 2025 were announced, and participating organisations will be featured in the upcoming ET Edge Coffee Table Book, with official logo licensing for the year.